FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCochlear Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
COH.AX
Cochlear Limited Stock AnalysisComprehensive stock analysis for Cochlear Limited (COH.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCOH.AX
COH.AX
Cochlear Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
COH.AX
  1. Home
  2. Stocks
  3. Cochlear Limited

Cochlear Limited

🇦🇺COH.AX•ASX

Cochlear Limited

🇦🇺COH.AX•ASX
P/E ratio
68.08

Your view on COH.AX

P/E
68.08
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cochlear Limited

Industry
Medical - Devices
Sector
Healthcare
CEO
Diggory William Howitt
Headquarters
1 University Avenue, Sydney, NSW, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Diggory William Howitt
Headquarters
1 University Avenue, Sydney, NSW, AU
Description

Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items.

Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Cochlear Limited from FRC's valuation model, read against the market price. COH.AX last traded at AUD 124.86, 68.1× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cochlear Limited. Starting points for Cochlear Limited: P/E 68.1, EPS AUD 2.25, beta 0.26 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Cochlear Limited. Cochlear Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cochlear Limited. Trailing twelve-month EPS for Cochlear Limited stands at AUD 2.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · AUD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrSep 2025Next QtrDec 2025Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 0.00AUD 3.15AUD 5.23AUD 5.72
Low estimateAUD 0.00AUD 3.15AUD 5.04AUD 5.10
High estimateAUD 0.00AUD 3.15AUD 5.61AUD 6.29
No. of analysts011314
Year-ago EPSAUD 2.15AUD 2.41AUD 2.251—
Growth−100.0%+30.7%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrSep 2025Next QtrDec 2025Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 1.22BAUD 1.22BAUD 2.39BAUD 2.52B
Low estimateAUD 1.22BAUD 1.22BAUD 2.26BAUD 2.38B
High estimateAUD 1.22BAUD 1.22BAUD 2.46BAUD 2.62B
No. of analysts611616
Year-ago revenueAUD 892.60MAUD 1.06BAUD 2.33B—
Growth+36.7%+14.3%+2.2%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cochlear Limited. Cochlear Limited has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold COH.AX17 companies · 8 funds
Compare COH.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
AT1.AXAtomo Diagnostics LimitedHealthcareMedical - Devices—
AVR.AXAnteris Technologies LtdHealthcareMedical - Devices—
CBL.AXControl Bionics LimitedHealthcareMedical - Devices—
EBR.AXEBR Systems, Inc.HealthcareMedical - Devices—
OSL.AXOncoSil Medical LtdHealthcareMedical - Devices—
PNV.AXPolyNovo LimitedHealthcareMedical - Devices—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
CBLLCeriBell, Inc.HealthcareNASDAQ$995.3M
CERSCerus CorporationHealthcareNASDAQ$391.8M
CGHCCapital Group Holdings, Inc.HealthcareOTC$9,220
CHEOFCochlear LimitedHealthcareOTC$8.9B
CHEOYCochlear LimitedHealthcareOTC$9.2B
CHYPFHealth Logic Interactive Inc.HealthcareOTC$165,839
CLLKFBICO Group AB (publ)HealthcareOTC$123.3M
CLPTClearPoint Neuro, Inc.HealthcareNASDAQ$247.1M
CLVSFCellaVision AB (publ)HealthcareOTC$378.0M
CMP.AXCompumedics LimitedHealthcareASX—
CNMDCONMED CorporationHealthcareNYSE$1.4B
ETFs holding Cochlear Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.02%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.02%
IEFAiShares Core MSCI EAFE ETF$188.8B in assets0.03%
SCZiShares MSCI EAFE Small-Cap ETF$12.6B in assets0.20%
WSRD.TOWealthsimple Developed Markets ex North America Socially Responsible Index ETF$926M in assets0.43%
FNDCSchwab Fundamental International Small Equity ETF$3.0B in assets0.13%
GSWOGoldman Sachs ActiveBeta World Equity ETF$1.7B in assets0.11%
XHC.TOiShares Global Healthcare Index ETF (CAD-Hedged)$631M in assets0.08%

Largest holders first, then the funds most concentrated in COH.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Cochlear Limited. Coverage tracks Cochlear Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cochlear Limited.

COH.AX AnalysisFair
Past
1
Growth
4
Health
4
Profit
2
Value
1

News

Latest Market News